Organization
Guangzhou University of Chinese Medicine
1 clinical trial
2 abstracts
Clinical trial
A Real-world Study of Lenvatinib Combined With Chinese Herbal Medicine for Patients With Unresectable Hepatocellular CarcinomaStatus: Completed, Estimated PCD: 2023-12-31
Abstract
Comparison of efficacy and safety of neoadjuvant regimens for resectable esophageal squamous cell carcinoma: A meta-analysis.Org: The First Hospital of Guangdong Pharmaceutical University, Cancer Hospital of Nanchang University, Guangdong Provincial People's Hospital, Guangzhou University of Chinese Medicine,
Abstract
Influence of CD47 on CD8+ T-cell and tumor prognosis based on pan-cancer analysis.Org: Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou University of Chinese Medicine, Southern Medical University,